No fault COVID-19 indemnity scheme

No fault COVID-19 indemnity scheme

For more information

The Australian Government has finalised the details of the no fault COVID-19 Vaccine Claim Scheme following extensive consultation with the peak medical, healthcare, business, and insurance sectors to ensure a comprehensive national scheme.

It will provide Australians with quick access to compensation for COVID-19 claims related to the administration of a Therapeutic Goods Administration approved COVID-19 vaccine delivered through a Commonwealth Government approved program. The scheme will be backdated to February 2021, and provide Australians with an alternative, administrative option to seek compensation, rather than a complex and costly court process.

Minister for Health and Aged Care, Greg Hunt, said the COVID-19 Vaccine Claims Scheme offers protection to Australians receiving a TGA approved COVID-19 vaccine, irrespective of where that vaccination occurs. “Side effects, or adverse events, from COVID-19 vaccinations can occur, but most are mild and last no longer than a couple of days. Serious and life-threatening side effects are very rare, but it is important that we provide a safety net to support those affected.”

“It also ensures that health professionals administering vaccines will be able to continue with their crucial role in the vaccine roll out with the assurance that the claims scheme will offer them protection.”

The scheme will be administered by Services Australia and will provide Australians with a single front door to a simple and quick administrative process for compensation.

The TGA will provide guidance on recognised adverse reactions as part of its established surveillance program. The cost of compensation payments under this scheme will be fully funded by the Commonwealth and is designed to help the small number of people who unfortunately experience a moderate to a significant adverse reaction to a COVID-19 vaccine.

The Royal Australian College of General Practitioners (RACGP) President Dr Karen Price welcomed it as a positive step forward, “This scheme is primarily to save patients having to go through complicated legal processes to seek compensation in the event of very rare side effects. GPs are the backbone of the vaccine rollout, delivering well over half of all vaccinations across Australia. It also provides peace of mind and protection for GPs working hard on the frontline of the
vaccine rollout.

“This is great news for patients right across the country because we know most patients want to get their COVID-19 vaccine from their usual GP, who knows their medical history and they trust to provide expert advice. I look forward to continuing to work with the Federal Government on the vaccine rollout. This is the largest mass vaccination program in living memory, and it is urgent.”

From 6 September, Australians who suffer injury and loss of income due to their COVID-19 vaccine will be able to register their intent to claim online. The scheme will cover the costs of injuries above $5,000 due to a proven adverse reaction to a COVID-19 vaccination. Claims will be assessed by independent experts, and compensation paid based on the recommendations.

Contact HDL

Contact HDL for any further information, contact us.

The information provided in this article is of a general nature only and has been prepared without taking into account your individual objectives, financial situation or needs. If you require advice that is tailored to your specific business or individual circumstances, please contact HDL.

HDL news, updates and publications may contain links to non-HDL websites that are created and controlled by other organisations. We claim no responsibility for the content of any linked website, or any link contained therein. The inclusion of any link does not imply endorsement by HDL, as we have no responsibility for information referenced in material owned and controlled by other parties. HDL strongly encourages you to review any separate terms of use and privacy policies governing use of these third party websites and resources.

Find this article helpful? Click on one of the links below to share the content.

Share on linkedin
Share on facebook
Share on twitter
Share on email